fbpx
01 / 05
The First Widespread Cure for HIV Could Be in Children

Wired | Noncommunicable Disease

The First Widespread Cure for HIV Could Be in Children

“Starting in the mid-2010s, the University of Oxford pediatrician and immunologist began working with scientists in the South African province of KwaZulu-Natal, with the aim of tracking several hundred children who had acquired HIV from their mothers, either during pregnancy, childbirth, or breastfeeding.

After putting the children on antiretroviral drugs early in their lives to control the virus, Goulder and his colleagues were keen to monitor their progress and adherence to standard antiretroviral treatment, which stops HIV from replicating. But over the following decade, something unusual happened. Five of the children stopped coming to the clinic to collect their drugs, and when the team eventually tracked them down many months later, they appeared to be in perfect health…

Goulder is now launching a new study to try and examine this phenomenon in more detail, taking 19 children in South Africa who have suppressed HIV to negligible levels on antiretrovirals, stopping the drugs, and seeing how many can prevent the virus from rebounding, with the aim of understanding why. To date, he says that six of them have been able to control the virus without any drugs for more than 18 months. Based on what he’s seen so far, he has a number of ideas about what could be happening. In particular, it appears that boys are more likely to better control the virus due to a quirk of gender biology to do with the innate immune system, the body’s first-line defense against pathogens.”

From Wired.

The New England Journal of Medicine | Noncommunicable Disease

Hospital-Acquired Infections Continue Decline Across US

“Prevalence surveys in U.S. hospitals showed that on any given day, 1 of 25 patients had a health care–associated infection in 2011, as compared with 1 of 31 patients in 2015. We repeated the survey in 2023 to assess changes in the prevalence of such infections…

The prevalence of health care–associated infections was lower in 2023 than in 2015, with 1 of 38 patients on any given day having such an infection; however, the burden of health care–associated infections in U.S. hospitals continued to be high.”

From The New England Journal of Medicine.

World Health Organization | Communicable Disease

El Salvador Eliminates Trachoma as a Public Health Problem

“The World Health Organization (WHO) has validated El Salvador as having eliminated trachoma as a public health problem. Trachoma is the world’s leading infectious cause of blindness…

Elimination of trachoma as a public health problem is defined as: (i) a prevalence of trachomatous trichiasis (TT) “unknown to the health system” of < 0.2% in ≥15-year-olds; and (ii) a prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years of < 5%, in each formerly endemic district; plus (iii) the existence of a system to identify and manage incident cases of TT.

Other countries validated by WHO as having eliminated trachoma as a public health problem are: Algeria, Australia, Benin, Burundi, Cambodia, China, Egypt, Fiji, Gambia, Ghana, India, Iraq, Islamic Republic of Iran, Lao People’s Democratic Republic, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Tunisia, Vanuatu and Viet Nam.

El Salvador is the first country in Central America and the second in the Americas to achieve this milestone.”

From World Health Organization.

Nigerian Tribune | Communicable Disease

Nigeria Nears Trachoma Elimination

“Nigeria is close to eliminating trachoma as a public health problem, with only 11 Local Government Areas (LGAs) left to achieve elimination, the Director of the National Trachoma Programme at the Federal Ministry of Health and Social Welfare, Nicholas Olobio, has said.

Olobio disclosed this on Thursday in Abuja during a learning event organised by Sightsavers to review progress under the AcceleraTE Trachoma Elimination Programme, which has supported Nigeria’s trachoma response since 2018.

He said Nigeria had made significant progress towards eliminating the blinding disease, revealing that mass drug administration (MDA) had been stopped in 116 LGAs, representing about 87 per cent of the country’s elimination target.”

From Nigerian Tribune.

UCL | Noncommunicable Disease

Trial Shows Safer Antibiotic Option for Staph Blood Infection

“The SNAP trial, funded in the UK by the National Institute for Health and Care Research (NIHR) found that a little used antibiotic, cefazolin, is as effective as and safer than the current UK standard therapy, flucloxacillin, for treating life-threatening staph blood infections. More than half of staph blood infections lead to sepsis and 15% to 25% of those who get these infections die within three months.

The researchers also found that a commonly used antibiotic, penicillin, can be used when the staph is treatable with this in the laboratory. And that similarly this is probably as effective as flucloxacillin, and safer.

The findings from the SNAP trial, published in the New England Journal of Medicine (NEJM) and The Lancet, challenge the long-held assumption that flucloxacillin should remain the default treatment and provide important new evidence to guide treatment strategy.”

From UCL.